MYCOMEDICA LIFE SCIENCES, PBC
Founded by world-renowned mycologist Paul Stamets, MycoMedica, PBC is a lifesciences company developing therapeutic drugs derived from fungi to help people live healthier, better lives. Our breakthrough innovation, the Stamets Stack, uses a novel combination of ingredients – not found together in nature – to unlock the potential effectiveness of psilocybin in the prevention and treatment of psychiatric and neurological disorders. More information is available at www.mycomedica.bio.
MYCOMEDICA LIFE SCIENCES, PBC
Industry:
Biotechnology Health Care Life Science
Founded:
2021-01-01
Address:
Shelton, Washington, United States
Country:
United States
Website Url:
http://www.mycomedica.bio
Total Employee:
11+
Status:
Active
Total Funding:
68 M USD
Similar Organizations
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Epigeneres Biotech Private Limited
Epigeneres Biotech Private Limited is a Biotechnology Company.
Glamnetic
Magnetic Eyelashes
Gryphon Bio, Inc.
Precision Medicine
Inner Cosmos
Inner Cosmos is the neurotechnology company that creates Brain Computer Interface (BCI) - NeuroMedicine.
Lyre's Spirit Co
Impossibly Crafted Non-Alcoholic Spirits
Lysosomal Therapeutics
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Neo Kuma Ventures
Psychedelic Healthcare Investment Fund
Psychic Connections Cedar Grove
psychic readings
Pura Mente
Meditation app in Spanish
Receptor
Investing in the future of psychedelic medicine.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Shaman Pharma
Psychedelics
The Spiral Electric
Psychedelic Rock
Current Advisors List
Current Employees Featured
Founder
Investors List
True Ventures
True Ventures investment in Series A - MycoMedica Life Sciences, PBC
Obvious Ventures
Obvious Ventures investment in Series A - MycoMedica Life Sciences, PBC
KittyHawk Ventures
KittyHawk Ventures investment in Series A - MycoMedica Life Sciences, PBC
Integrated Investment Partners
Integrated Investment Partners investment in Series A - MycoMedica Life Sciences, PBC
Obvious Ventures
Obvious Ventures investment in Seed Round - MycoMedica Life Sciences, PBC
Official Site Inspections
http://www.mycomedica.bio Semrush global rank: 4.5 M Semrush visits lastest month: 2.38 K
- Host name: 104.21.74.211
- IP address: 104.21.74.211
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "MycoMedica Life Sciences, PBC"
MycoMedica Life Sciences, PBC | psilocybin medicines
MycoMedica Life Sciences is a pioneering biopharmaceutical company whose mission is to revolutionize the development of a new class of safe and efficacious psychedelic medications for mental health and neurodegenerative disorders.See details»
About - Mycomedica
We are exploring groundbreaking treatment options to transform lives. We are a team of mission-based scientists, clinicians, researchers, and business executives, connected through our passion to provide better treatment …See details»
MycoMedica Life Sciences, PBC - Crunchbase
Psilocybin in the prevention and treatment of psychiatric and neurological disorders. More information is available at www.mycomedica.bio. Develops psilocybin-based medications for conditions like PMDD, OCD, OUD, and …See details»
MycoMedica Life Sciences, PBC - The Org
MycoMedica Life Sciences is a pioneering biopharmaceutical company whose mission is to revolutionize the development of a new class of safe and efficacious psychedelic medications …See details»
MycoMedica Life Sciences, PBC Secures $60 Million in
Jun 1, 2022 · Founded by world-renowned mycologist Paul Stamets, MycoMedica, PBC is a lifesciences company developing therapeutic drugs derived from fungi to help people live …See details»
MycoMedica Life Sciences - VentureRadar
Website: http://www.mycomedica.bio/ Develops therapeutic drugs from fungi for healthier living, including the innovative Stamets Stack, targeting prevention and treatment of psychiatric and …See details»
MycoMedica Life Sciences, PBC - LinkedIn
MycoMedica Life Sciences is a pioneering biopharmaceutical company whose mission is to revolutionize the development of a new class of safe and efficacious psychedelic medications for mental...See details»
Enveric Biosciences Signs Out-Licensing Agreement with …
Nov 12, 2024 · MycoMedica will receive an exclusive, global license to the formulations, drugs, method of use, and medical devices developed by Enveric to utilize the compound. …See details»
Programs - Mycomedica
Programs | Mycomedica. Clinically Meaningful Improvements. Science, helping people get their lives back. Our trials are designed to evaluate the safety of low doses of psilocybin, utilizing a novel dosing paradigm to optimize …See details»
MycoMedica Life Sciences, PBC Secures $60 Million in …
Jun 3, 2022 · MycoMedica Life Sciences, PBC, a new company focused on developing and delivering fungi-based therapeutic drugs to prevent and treat psychiatric and neurological disorders, today announced it has raised $60 …See details»
MycoMedica Life Sciences, PBC Secures $60 Million in Funding To …
SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- Life Itself Conference – MycoMedica Life Sciences, PBC, a new company focused on developing and delivering fungi-based therapeutic …See details»
MycoMedica - Company Profile - Tracxn
Nov 7, 2024 · MycoMedica - Life sciences company focused on developing therapeutic drugs derived from fungi to help prevent and treat psychiatric and neurological disorders. Raised a …See details»
MycoMedica Life Sciences - Overview, News & Similar ... - ZoomInfo
May 31, 2022 · View MycoMedica Life Sciences (mycomedica.bio) location in California, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Contact - Mycomedica
We are redefining Mental Wellness by bringing together Tradition and Technology to improve the lives of our patients. For media or investor inquiries, or to request any additional information, …See details»
MycoMedica Life Sciences Secures Funding - Paul Stamets
Jun 30, 2023 · MycoMedica Life Sciences has secured $60 million in funding to fuel fungi based drug development for prevention and treatment of psychiatric and neurological disorders.See details»
Enveric Biosciences Signs Out-Licensing Agreement with …
Nov 12, 2024 · MycoMedica will receive an exclusive, global license to the formulations, drugs, method of use, and medical devices developed by Enveric to utilize the compound. …See details»
Paul Stamets - Crunchbase Person Profile
Paul Stamets is the Co-founder and CEO, MycoMedica Life Sciences, PBC at MycoMedica Life Sciences, PBC.See details»
MycoMedica Life Sciences - PitchBook
Dec 27, 2021 · Information on valuation, funding, cap tables, investors, and executives for MycoMedica Life Sciences. Use the PitchBook Platform to explore the full profile. Request a …See details»
MycoMedica Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for MycoMedica. Use the PitchBook Platform to explore the full profile. Request a free trial Log inSee details»
MycoMedica | grzyby witalne - MycoMedica - grzyby lecznicze
BezpÅ‚atne doradztwo. Optymalny udziaÅ‚ polisacharydów. Pomagamy 10 lat. Testowano w niezależnym laboratorium. JesteÅ›my numerem jeden w Europie. Matka Natura. Watch on. …See details»